How the Aortic Valve Market Has Witnessed Substantial Growth in Coming Years?

Posted by Pramod Arya on June 10th, 2021

Valued at ,568.3 billion in 2019, the global aortic valve market is predicted generate a revenue of ,146.9 million in 2030. Furthermore, as per P&S Intelligence, a market research firm based in India, the market is predicted to advance at a CAGR of 13.2% from 2020 to 2030.

The soaring incidence of aortic regurgitation and aortic stenosis is the prominent factor causing the surge of the aortic valve market across the globe. RHD (rheumatic heart disease) is the leading cause of aortic regurgitation. As per the findings of the World Health Organization (WHO), around 2% of the people suffering from cardiovascular diseases all over the world have RHD. It basically means that nearly 33 million people in the entire world are suffering from RHD. 

Receive Sample Copy of this Report:https://www.psmarketresearch.com/market-analysis/aortic-valve-market/report-sample

As per the findings of John Muir Health, which is a non-profit integrated system for hospitals, doctors, and other medical practitioners, over five million people around the world are diagnosed with aortic stenosis and various other heart valve diseases every year. Furthermore, the organization found that in the U.S., aortic stenosis affects 1.5 million people every year. The incidence of this disease rises with growing age and therefore, the increasing geriatric population is another major growth driver of the market.

Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=aortic-valve-market

The key factors causing the boom of the European market are the existence of advanced healthcare facilities and infrastructure, increasing healthcare spending, surging geriatric population, the soaring incidence of lifestyle-associated and chronic diseases in the regional countries. Additionally, the rising public awareness programs launched by the governments of regional countries and the development of highly effective treatments such as TAVR (transcatheter aortic valve replacement) are further boosting the rate of advancement of the market.